Minimization of MR contrast weightings for the comprehensive evaluation of carotid atherosclerotic disease

Investigative Radiology

Volumn 45, Issue 1, 2010, Pages 36-41

  Zhao, Xihai ^a   Underhill, Hunter R ^a   Yuan, Chun ^a   Oikawa, Minako ^a   Dong, Li ^a   Ota, Hideki ^a   Hatsukami, Thomas S ^b   Wang, Qingjun ^c   Ma, Lin ^c   Cai, Jianming ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Atherosclerosis; Carotid artery; Magnetic resonance imaging

Indexed keywords

GADODIAMIDE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CALCIFICATION; CAROTID ARTERY OBSTRUCTION; CONTRAST ENHANCEMENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPRODUCIBILITY;

EID: 74049099553     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181beada7     Document Type: Article

References (47)

1. Mitsumori LM, Hatsukami TS, Ferguson MS, et al. In vivo accuracy of multisequence MR imaging for identifying unstable fibrous caps in advanced human carotid plaques. J Magn Reson Imaging. 2003;17:410-420.
2. Yuan C, Mitsumori LM, Ferguson MS, et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation. 2001;104:2051-2056.
3. Saam T, Ferguson MS, Yarnykh VL, et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol. 2005; 25:234-239.
4. Trivedi RA, U-King-Im J, Graves MJ, et al. Multi-sequence in vivo MRI can quantify fibrous cap and lipid core components in human carotid atherosclerotic plaques. Eur J Vasc Endovasc Surg. 2004;28:207-213.
5. Puppini G, Furlan F, Cirota N, et al. Characterisation of carotid atherosclerotic plaque: comparison between magnetic resonance imaging and histology. Radiol Med. 2006;111:921-930.
6. Clarke SE, Hammond RR, Mitchell JR, et al. Quantitative assessment of carotid plaque composition using multicontrast MRI and registered histology. Magn Reson Med. 2003;50:1199-1208.
7. Yarnykh VL, Yuan C. T1-insensitive flow suppression using quadruple inversion-recovery. Magn Reson Med. 2002;48:899-905.
8. Yarnykh VL, Yuan C. Multislice double inversion-recovery black-blood imaging with simultaneous slice reinversion. J Magn Reson Imaging. 2003; 17:478-483.
9. Yuan C, Beach KW, Smith LH Jr, et al. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation. 1998;98:2666-2671.
10. Zhang S, Suri JS, Salvado O, et al. Inter-and intra-observer variability assessment of in vivo carotid plaque burden quantification using multi-contrast dark blood MR images. Stud Health Technol Inform. 2005;113:384-393.
11. Kampschulte A, Ferguson MS, Kerwin WS, et al. Differentiation of in-traplaque versus juxtaluminal hemorrhage/thrombus in advanced human carotid atherosclerotic lesions by in vivo magnetic resonance imaging. Circulation. 2004;110:3239-3244.
12. Cappendijk VC, Cleutjens KB, Heeneman S, et al. In vivo detection of hemorrhage in human atherosclerotic plaques with magnetic resonance imaging. J Magn Reson Imaging. 2004;20:105-110.
13. Chu B, Kampschulte A, Ferguson MS, et al. Hemorrhage in the atherosclerotic carotid plaque: a high-resolution MRI study. Stroke. 2004;35:1079-1084.
14. Takaya N, Yuan C, Chu B, et al. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation. 2005;111:2768-2775.
15. Hatsukami TS, Ross R, Polissar NL, et al. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging. Circulation. 2000;102:959-964.
16. Yuan C, Zhang SX, Polissar NL, et al. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation. 2002;105:181-185.
17. Winn WB, Schmiedl UP, Reichenbach DD, et al. Detection and characterization of atherosclerotic fibrous caps with T2-weighted MR. Am J Neuro-radiol. 1998;19:129-134.
18. Wasserman BA, Smith WI, Trout HH III, et al. Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results. Radiology. 2002;223:566-573.
19. Cai J, Hatsukami TS, Ferguson MS, et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation. 2005;112:3437-3444.
20. Takaya N, Cai J, Ferguson MS, et al. Intra-and inter-reader reproducibility of magnetic resonance imaging for quantifying the lipid-rich necrotic core is improved with gadolinium contrast enhancement. J Magn Reson Imaging. 2006;24:203-210.
21. Yuan C, Kerwin WS, Yarnykh VL, et al. MRI of atherosclerosis in clinical trials. NMR Biomed. 2006;19:636-654.
22. Hayes CE, Mathis CM, Yuan C. Surface coil phased arrays for high-resolution imaging of the carotid arteries. J Magn Reson Imaging. 1996;6: 109-112.
23. Yarnykh VL, Terashima M, Hayes CE, et al. Multicontrast black-blood MRI of carotid arteries: comparison between 1.5 and 3 tesla magnetic field strengths. J Magn Reson Imaging. 2006;23:691-698.
24. Underhill HR, Yarnykh VL, Hatsukami TS, et al. Carotid plaque morphology and composition: initial comparison between 1.5-and 3.0-T magnetic field strengths. Radiology. 2008;248:550-560.
25. Kang X, Polissar NL, Han C, et al. Analysis of the measurement precision of arterial lumen and wall areas using high-resolution MRI. Magn Reson Med. 2000;44:968-972.
26. Underhill HR, Yuan C, Terry JG, et al. Differences in carotid arterial morphology and composition between individuals with and without obstructive coronary artery disease: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2008;10:31.
27. Kerwin W, Xu D, Liu F, et al. Magnetic resonance imaging of carotid atherosclerosis: plaque analysis. Top Magn Reson Imaging. 2007;18:371-378.
28. Oppo K, Leen E, Angerson WJ, et al. Doppler perfusion index: an interob-server and intraobserver reproducibility study. Radiology. 1998;208:453-457.
29. Zhang S, Hatsukami TS, Polissar NL, et al. Comparison of carotid vessel wall area measurements using three different contrast-weighted black blood MR imaging techniques. Magn Reson Imaging. 2001;19:795-802.
30. Phan BA, Chu B, Kerwin WS, et al. Effect of contrast enhancement on the measurement of carotid arterial lumen and wall volume using MRI. J Magn Reson Imaging. 2006;23:481-485.
31. Yarnykh VL, Yuan C. Simultaneous outer volume and blood suppression by quadruple inversion-recovery. Magn Reson Med. 2006;55:1083-1092.
32. Saam T, Cai J, Ma L, et al. Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging. Radiology. 2006;240:464-472.
33. Takaya N, Yuan C, Chu B, et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI-initial results. Stroke. 2006;37:818-823.
34. Ota H, Yarnykh VL, Ferguson MS, et al. Carotid intraplaque hemorrhage imaging at 3.0-tesla MRI: a comparison of the diagnostic performance of three T1-weighted sequences. Radiology. In press.
35. de Bazelaire CM, Duhamel GD, Rofsky NM, et al. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology. 2004;230:652-659.
36. Gold GE, Han E, Stainsby J, et al. Musculoskeletal MRI at 3.0 T: relaxation times and image contrast. Am J Roentgenol. 2004;183:343-351.
37. Cai JM, Hatsukami TS, Ferguson MS, et al. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 2002;106:1368-1373.
38. Underhill HR, Yuan C, Yarnykh VL, et al. Predictors of surface disruption with MR imaging in asymptomatic carotid artery stenosis. Am J Neuroradiol. Epub ahead of print.
39. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006;21:1104-1108.
40. Rydahl C, Thomsen HS, Marckmann P. High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent. Invest Radiol. 2008;43:141-144.
41. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology. 2007;243:148-157.
42. Wiginton CD, Kelly B, Oto A, et al. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. Am J Roentgenol. 2008;190:1060-1068.
43. Varani J, DaSilva M, Warner RL, et al. Effects of gadolinium-based magnetic resonance imaging contrast agents on human skin in organ culture and human skin fibroblasts. Invest Radiol. 2009;44:74-81.
44. Saam T, Hatsukami TS, Yarnykh VL, et al. Reader and platform reproduc-ibility for quantitative assessment of carotid atherosclerotic plaque using 1.5T Siemens, Philips, and General Electric scanners. J Magn Reson Imaging. 2007;26:344-352.
45. DeLano MC, DeMarco JK. 3.0 T versus 1.5 T MR angiography of the head and neck. Neuroimaging Clin N Am. 2006;16:321-341, xi.
46. Yamada N, Higashi M, Otsubo R, et al. Association between signal hyper-intensity on T1-weighted MR imaging of carotid plaques and ipsilateral ischemic events. Am J Neuroradiol. 2007;28:287-292.
47. Bitar R, Moody AR, Leung G, et al. In vivo 3D high-spatial-resolution MR imaging of intraplaque hemorrhage. Radiology. 2008;249:259-267.